The story appears on

Page A2

June 23, 2012

GET this page in PDF

Free for subscribers

View shopping cart

Related News

Home » Metro » Health and Science

Viral hepatitis to be controllable in future

VIRAL hepatitis is likely to be controllable in 20 years with the development of hepatitis vaccines and immunity medicine, medical experts told an international symposium on viral hepatitis and liver disease in Shanghai yesterday.

Viral hepatitis is the most prevalent of 28 serious infectious diseases in China with an incidence of 0.1 percent.

Over 1.37 million Chinese were diagnosed with viral hepatitis last year - 42.4 percent of all cases among the 28 serious infectious diseases. Liver cancer, mainly caused by viral hepatitis, has the second-highest mortality among all cancers.

Thanks to the promotion of hepatitis B vaccination, the incidence of hepatitis B carriers dropped from 9.75 percent in 1992 to the current 7.17 percent, which means 30 million Chinese have avoided catching the virus in the past decade, experts told the symposium, attended by some 2,500 participants from 44 countries and regions.

Research on viral hepatitis and liver cancer in China has improved greatly in recent years, experts said. More Chinese scientists have had articles published on the topic in scientific journals recently than any other country except the United States.

Dr Wang Hongyang, a medical researcher and member of the Chinese Academy of Engineering, said during the symposium that he has discovered a series of liver cancer markers for early cancer identification. He said the current cancer marker diagnosis has an accuracy rate of 40 percent, while his measure can increase the accuracy rate of early diagnosis by 15 percent points.

It has received a patent in China and is being appraised by the State Food and Drug Administration.


Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend